Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

RSS icon
Thumbnail

Illumina ordered to divest Grail

The agency, which is charged with preventing fraud, deception and unfair business practices, said Illumina’s acquisition of Grail would stifle competition and innovation in the U.S. market for life-saving cancer tests.

FDA turns up sterility issues at eye drop facility linked to deaths, vision loss

The FDA has found a drug-resistant bacteria at an eye drop manufacturing facility linked to severe infections and even a few deaths.

Thumbnail

Affordable Care Act dealt a blow in new judgment

The Affordable Care Act (ACA) was dealt a major blow after a federal judge ruled that employers don’t have to cover certain preventive services, including PReP, which prevents HIV.

Telehealth use plummets after pandemic highs

Use of the telehealth soared in 2020, but utilization has since fallen off a cliff after changing conditions of the COVID-19 pandemic. 

Microsoft Johns Hopkins AI partnership

7 lessons learned during joint big business/healthcare AI projects

Big Tech players have been investing in partnerships with large healthcare providers on AI endeavors for several years now. According to both sides in one such collaboration, the resulting synergy offers “immense potential” to improve patient access, care and outcomes.

Johnson & Johnson scraps RSV vaccine after trial

The move comes as RSV has been on the rise in the United States.

Nurses plan to stay in the field, but they want more progress

A total of 80% of nurses plan to stay in healthcare until retirement––way up from the 55% who said the same in 2022.

files paperwork work load

UnitedHealthcare to cut back on prior authorization paperwork

UnitedHealthcare announced it would remove 20% of its current prior authorizations starting with the third quarter of this year. 

 

Displaying 305 - 312 of 573

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup